ArticleUrolithiasis2025
Global, regional, and nation burden of urolithiasis in young adults from 1990 to 2021: analysis of data from the global burden of disease study 2021.
Article in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Epidemiology and risk factors of urolithiasis in the Turkestan region: a case-control study.Scientific reports · 2026Article
- Global, Regional, and National Burden of Acute Abdominal Conditions in Females-Appendicitis, Ectopic Pregnancy, Paralytic Ileus and Intestinal Obstruction, and Urolithiasis, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021 with ARIMA Projections to 2030.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global burden of urolithiasis has attracted increasing attention, but there is still a lack of data on the trends and regional disparities of urolithiasis among young adults. Utilizing data from the Global Burden of Disease (GBD) 2021 Results Tool, this study analyzed annual incidence and disability-adjusted life years (DALYs) rates across 204 countries and 21 regions among young adults aged 15-49 years. Age-standardized rates (ASRs) were calculated to facilitate direct comparisons, and temporal trends were assessed using the Joinpoint Regression Program to determine average annual percentage changes (AAPC). The relationship between urolithiasis burden and the sociodemographic index (SDI) was evaluated through Spearman and Pearson correlation analyses. Globally, the number of incident cases rose from 34.6 million in 1990 to 50.7 million in 2021, while the ASR of incidence declined (AAPC: - 0.35%, 95% confidence interval[CI]: - 0.38% to - 0.29%). Similarly, the ASR of DALYs decreased (AAPC: -0.71%, 95% CI: -0.80% to - 0.62%). Males consistently exhibited higher ASRs than females, though both sexes showed declining trends. Regions with higher SDI values experienced decreasing burdens, while some low- and low-middle SDI regions saw increasing ASRs. In 2021, Eastern Europe recorded the highest ASRs of incidence and DALYs, whereas South Asia reported the highest absolute number of cases. A significant positive correlation was observed between SDI and ASR of incidence. These findings underscore the shifting global burden of urolithiasis among young adults, with a general decline in incidence and DALYs over the past three decades. However, the increasing trends in certain low SDI regions highlight the need for targeted public health interventions to address regional disparities.
Indexed as
Identifiers
39985667What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.